Zobrazeno 1 - 10
of 122
pro vyhledávání: '"Annemiek M E, Walenkamp"'
Autor:
Emile B. Veenstra, Adrienne H. Brouwers, Derk Jan A. de Groot, Johannes Hofland, Annemiek M. E. Walenkamp, Tessa Brabander, Wouter T. Zandee, Walter Noordzij
Publikováno v:
European Journal of Hybrid Imaging, Vol 6, Iss 1, Pp 1-11 (2022)
Abstract Background In treatment of neuroendocrine neoplasms (NENs), confirmation of somatostatin receptor expression with 68Ga-DOTA somatostatin analogues is mandatory to determine eligibility for peptide receptor radionuclide therapy (PRRT). [18F]D
Externí odkaz:
https://doaj.org/article/1a243b2f663f4ad9a388ef25fd899542
Autor:
Gilles N. Stormezand, Romano S. B. H. Schreuder, Adrienne H. Brouwers, Riemer H. J. A. Slart, Philip H. Elsinga, Annemiek M. E. Walenkamp, R. A. J. O. Dierckx, Andor W. J. M. Glaudemans, Gert Luurtsema
Publikováno v:
EJNMMI Research, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Background 6-[18F]fluoro-l-3,4-dihydroxyphenyl alanine ([18F]FDOPA) is a commonly used PET tracer for the detection and staging of neuroendocrine tumors. In neuroendocrine tumors, [18F]FDOPA is decarboxylated to [18F]dopamine via the enzyme
Externí odkaz:
https://doaj.org/article/dc3240459fec4e689f280f43c2b7fcea
Autor:
Geertruida H De Bock, Marjolein Y Berger, Daan Brandenbarg, Famke Huizinga, Nico-Derk Lodewijk Westerink, Annette J Berendsen, Annemiek M E Walenkamp, Mathieu H G de Greef
Publikováno v:
BMJ Open, Vol 12, Iss 3 (2022)
Introduction Physical activity (PA) favourably affects various health outcomes in cancer survivors, but little is known about how to implement a PA programme in primary care. We therefore aim to implement and evaluate such a programme for cancer surv
Externí odkaz:
https://doaj.org/article/13e49f4f66594a888fe274a6c8f5aade
Autor:
Si-Qi Qiu, Johan van Rooijen, Hilde H. Nienhuis, Bert van der Vegt, Hetty Timmer-Bosscha, Elise van Leeuwen-Stok, Annemiek M. E. Walenkamp, Carolien H. M. van Deurzen, Geertruida H. de Bock, Elisabeth G. E. de Vries, Carolien P. Schröder
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-10 (2020)
Abstract Background Breast cancer is rare in men, but management is focused on tumor characteristics commonly found in female breast cancer. The tumor microenvironment of male breast cancer is less well understood, and insight may improve male breast
Externí odkaz:
https://doaj.org/article/6dac41f9d188433fb23a4a389a57ad75
Autor:
Annette W.G. van der Velden, Jourik A. Gietema, Aline H. Vrieling, Harm L Ormel, Carolina P. Schröder, Annemiek M E Walenkamp, Gabriela G. F. van der Schoot, Anna K.L. Reyners, Boelo Jan Poppema, Nico-Derk L. Westerink
Publikováno v:
Breast, Vol 58, Iss, Pp 138-146 (2021)
The Breast : Official Journal of the European Society of Mastology
The Breast, 58, 138-146. Churchill Livingstone
The Breast : Official Journal of the European Society of Mastology
The Breast, 58, 138-146. Churchill Livingstone
Background Adjuvant endocrine therapy (ET) in patients with breast cancer (BC) increases the risk of becoming less physically active. Physical inactivity is associated with a higher risk of treatment-related side effects and mortality. This study inv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3d85fc0dab4bf373b6be0eea42769af
http://www.sciencedirect.com/science/article/pii/S0960977621003763
http://www.sciencedirect.com/science/article/pii/S0960977621003763
Autor:
Emile B Veenstra, Derk Jan A. de Groot, Annemiek M E Walenkamp, Adrienne H. Brouwers, Walter Noordzij
Publikováno v:
Clinical Nuclear Medicine, 46(3), 195-200. LIPPINCOTT WILLIAMS & WILKINS
PurposeThe aim of this study was to retrospectively compare F-18-FDOPA versus Ga-68-DOTATOC PET in lesion detection rates and laboratory tumor markers in patients with neuroendocrine neoplasms (NENs). Patients and MethodsAll patients with histologica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edd4b07fa496c9f0358bcf841f6e173f
https://hdl.handle.net/11370/f1173269-aa27-46d7-85e3-291ed6ff13c7
https://hdl.handle.net/11370/f1173269-aa27-46d7-85e3-291ed6ff13c7
Autor:
Ido P. Kema, Elisabeth G.E. de Vries, Annemiek M E Walenkamp, Coby Meijer, Marloes A M Peters, Sjoukje F. Oosting
Publikováno v:
Drug Resistance Updates. 53:96-104
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5d01725d78c8ec4c47bbe159ca494d7
https://research.rug.nl/en/publications/ebd8c557-ebdf-4cf4-be60-b013d6365335
https://research.rug.nl/en/publications/ebd8c557-ebdf-4cf4-be60-b013d6365335
Autor:
Coby Meijer, Ido P. Kema, Rudolf S N Fehrmann, Marloes A M Peters, Elisabeth G.E. de Vries, Harry Hollema, Annemiek M E Walenkamp, Sjoukje F. Oosting
Publikováno v:
Pathology & oncology research, 26(3), 1539-1547. SPRINGER
Pathology Oncology Research
Pathology Oncology Research
In preclinical studies serotonin stimulates and dopamine inhibits tumour growth and angiogenesis. Information regarding serotonin and dopamine receptor (5-HTR and DRD) expression in human cancers is limited. Therefore, we screened a large tumour set
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc89c25437d3f005021f7654c4746878
https://hdl.handle.net/11370/c9ece3d4-68f8-4de0-ae07-ed408dda19d2
https://hdl.handle.net/11370/c9ece3d4-68f8-4de0-ae07-ed408dda19d2
Autor:
Elisabeth G.E. de Vries, Ido P. Kema, Marian Bulthuis, Annemiek M E Walenkamp, Gursah Kats-Ugurlu, Martijn van Faassen, Tim J Takkenkamp, Lotte D de Hosson, Grietje Bouma
Publikováno v:
Cancer Immunology, Immunotherapy
Cancer Immunology Immunotherapy, 69(8), 1449-1459. SPRINGER
Cancer Immunology Immunotherapy, 69(8), 1449-1459. SPRINGER
Tumours can escape the immune system by expressing programmed death-ligand-1 (PD-L1), which allows them to bind to PD-1 on T-cells and avoid recognition by the immune system. Regulatory T-cells (Tregs), indoleamine 2,3-dioxygenase (IDO) and tryptopha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1aef18dbc9ed252cdb8c5c9f3c8c1172
https://doi.org/10.1007/s00262-020-02556-1
https://doi.org/10.1007/s00262-020-02556-1
Autor:
Gabriela G F, van der Schoot, Harm L, Ormel, Nico-Derk L, Westerink, Anne M, May, Sjoerd G, Elias, Yoran M, Hummel, Joop D, Lefrandt, Peter, van der Meer, Joost P, van Melle, Boelo J, Poppema, Joyce M A, Stel, Annette W G, van der Velden, Aline H, Vrieling, Johan B, Wempe, Marcel G, Ten Wolde, Marcel, Nijland, Elisabeth G E, de Vries, Jourik A, Gietema, Annemiek M E, Walenkamp
Publikováno v:
JACC. CardioOncology. 4(4)
Despite the widely acknowledged benefit of exercise for patients with cancer, little evidence on the optimal timing of exercise on adverse effects of cancer treatment is available.The aim of this study was to determine whether an exercise interventio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ef75e925faf113dc218fe170c1cde1d6
https://pubmed.ncbi.nlm.nih.gov/36444224
https://pubmed.ncbi.nlm.nih.gov/36444224